Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 136.75M P/E - EPS this Y 8.30% Ern Qtrly Grth -
Income -25.91M Forward P/E -4.32 EPS next Y -22.70% 50D Avg Chg 4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 33.00%
Dividend N/A Price/Book 1.21 EPS next 5Y - 52W High Chg -22.00%
Recommedations 2.00 Quick Ratio 13.96 Shares Outstanding 125.76M 52W Low Chg 116.00%
Insider Own 0.06% ROA -19.68% Shares Float 117.92M Beta 1.20
Inst Own 27.43% ROE -28.01% Shares Shorted/Prior 13.18M/12.86M Price 1.08
Gross Margin - Profit Margin - Avg. Volume 958,264 Target Price 5.50
Oper. Margin - Earnings Date Nov 11 Volume 450,656 Change -1.82%
About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Atossa Therapeutics, Inc. News
11/21/24 Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research
11/20/24 Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium
11/18/24 Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
11/12/24 Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
11/05/24 Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development
11/04/24 Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
10/31/24 Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer
10/28/24 Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
10/21/24 Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer
10/14/24 Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit
10/01/24 Atossa Therapeutics Commemorates Breast Cancer Awareness Month, Highlighting the Need for Innovation Across the Breast Cancer Treatment Continuum
09/19/24 Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
09/10/24 Atossa Therapeutics Announces Support of Final Rule from FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
09/03/24 Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
09/03/24 Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
08/30/24 Are You Looking for a Top Momentum Pick? Why Atossa Genetics Inc. (ATOS) is a Great Choice
08/28/24 Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
08/21/24 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer
08/20/24 Atossa Therapeutics Announces the Appointment of Michael Parks as Vice President, Investor and Public Relations
08/12/24 Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
ATOS Chatroom

User Image MaverickDragon Posted - 2 hours ago

$ATOS now this is gold !! Thanks @drjnightowl

User Image Alih81 Posted - 3 hours ago

$ATOS this is for longs. Day traders take advantage on daily basis.

User Image CaneloMoh Posted - 5 hours ago

$ATOS Genz kid who invested 5k in crypto has 20k in return. Meanwhile Atossa investors....

User Image Smouty95 Posted - 6 hours ago

$ATOS if nothing happens after SABCS & AACR I’m 100% out. Around 5 years I’ve been invested and the most patient I’ve ever been. Went out on a limb and have doubled down buying another 1900 shares this week. However; that’s it. I’ll give it until around 15th Dec, if nothing, I’m out. For good. Been super bullish but it’s exhausting, I can’t keep my money tied up for this long, crypto popping is just the extra blow I didn’t need. Love the community however, and will miss it ✌🏼 glta

User Image Benjie5 Posted - 6 hours ago

$ATOS we live in a world where fucking XRP and Doge and all this other bullshit goes up 100-200% in a month but a breast cancer treatment can’t even go up 30% … 🤦 pathetic … ppl can’t even tell me what a fucking crypto coin is but it makes them way more money then this shit.. sorry for the rant but I’m starting to get impatient 🤦

User Image scrappy_trader Posted - 7 hours ago

@kinooo @MPJ_18 Dr Quay is a brilliant scientist has his principles, integrity and stands by it Other CEO's may be commercially oriented pushing for SP. Feel Quay covid followup is going to work out in favor of $ATOS in the end

User Image Bunster Posted - 7 hours ago

$ATOS fireside chat has been postponed. just where we stand for now is below 5 posters coming out in san antonio 1 poster coming out in toronto 80 mg data coming patent decision coming Quays 100 million dollar atm offering is upon us big money is controlling many small bios and we are not exempt from it. prime

User Image gemininvi Posted - 7 hours ago

$ATOS so i just read through the whole patent dispute and it's a really tough one. I still believe patent owner ( atossa) has a point that Ahmad does not show any significant way to purify Z-endoxifin because of the lack of chemistry key factors in the initial patent of ahmad. Ahmad just claims that a POSA could recreate Z using their formulation and way of working which is scientifically completly biased. From what i read Ahmad says you can make an omelet with eggs. But doens't specify temprature, cooking time, adding of salt or pepper,... Wheras patent owner descripes all of this to make a 3 stars omelet. Did i get it right or not ? Also when is the closing date of this ?

User Image VegasG Posted - 9 hours ago

$ATOS Cheap shares don’t suck but dammit I want to see an SP that has a first number that that’s a couple digits larger than 2!

User Image Bunster Posted - 9 hours ago

$ATOS you canr make this up. For 6 plus years prime was telling u why he did not like quay. All these posters worshipped quay like they use to hannibal until the jagx debacle happened and yes some did not like quay spending so much time on the origins of covid but just today BOTH THE OWL AND 24 7 TURNED ON QUAY. Once again one of the most used sayings on our mb,PRIME was right.

User Image ColeCapInvests Posted - 10 hours ago

$SLS $ATOS I just got alerted that a stop loss raid happened and tick tick tick….So the Ship got loaded even more. 🤔

User Image drjnightowl Posted - 10 hours ago

$ATOS Given that I've provided commentary on previous filings from the PGR, I'll conclude with my thoughts after having read the oral arguments. The strongest part of Atossa's position was, in my opinion, the fact that Intas's POSA (chemist) was unable to synthesize (Z)-Endoxifen using Ahmad (Intas's patent) and in fact never even bothered trying. Instead, he used another guy's patent (Liu), and had to tinker around with it somewhat to be successful. This affirms Atossa's stance that Intas's patent (Ahmad) was too broad and not enabling (meaning, it didn't actually teach how to make (Z), only that it could be made). Now this also comes at a price.... the fact that a POSA was in fact able to make Atossa's (Z)-Endox by following someone else's patent with minor deviations isn't a good look. Atossa's patent basically says "(Z) can be done, here's how you would do it, and why." Whereas there are three separate documents out there that, when combined, give the same idea. Continued...

User Image dcajic2 Posted - 10 hours ago

$ATOS Bulls are delusional with this one. This is still an early phase company that will not have a licensing deal or partnership deal for at least two years. When they wanted a few years back those shelf shares and shareholders said no way this is why the stock is low right now. The shares would have helped with a deal. Now it’s just a waiting game to see if at the end of the two years they will have good results for phase 2

User Image dcajic2 Posted - 10 hours ago

$ATOS Intas is big and atossa is little. This is not a fair world. Intas will likely win

User Image NotHopeJustFacts Posted - 10 hours ago

@GringotsAG out of 100 humans, 100 gets a bowel movement, don't forget that my dear clowns, especially when buying yourself another POS like this one $ATOS

User Image dcajic2 Posted - 10 hours ago

$ATOS Reality land. They are likely to lose patent dispute. Why do you think most people settle.

User Image GringotsAG Posted - 10 hours ago

$ATOS are we see some traction over here ? -Out of 3 women, 1 gets breast cancer-. Dont forget that my dear bulls

User Image doodledo77 Posted - 11 hours ago

$ATOS wait don't reverse yet 🙏🔥😂💚

User Image waterboy182 Posted - 11 hours ago

$ATOS Do your own pretty easy DD on this one. Our probable poop Noodler of the year guy posts 'week in review' early today cuz he can't be here later... Well, he is silent and so are his other accounts all day. They have been posting crap constantly until now. Lol. If you had any doubts before...

User Image Bullrunners Posted - 11 hours ago

$ATOS $SLS Again the meet each other at the same level

User Image AnnieRipley Posted - 11 hours ago

$ATOS Claims need to be proven by the Intas guys. This was also a great response IMO “our Patent Owner preliminary response at pages 3 and 4 clearly states that acetic acid of Ahmad results in isomerization. So this is not a new argument. And I believe Dr. Bihovsky and perhaps Dr. McConnell both agreed that if you put an unstable Z isomer in acid, it will isomerize.” 👏👏👏 Dr. Quay knows his formulation and to defend what is his. 🙏💪

User Image willshakespeare112 Posted - 11 hours ago

$ATOS just a fun comparison Bitcoin went from 9k to 99k from 2020-24 This went from 1 to 1.2 😂😂😂

User Image AnnieRipley Posted - 11 hours ago

$ATOS The Intas guys didn't even submit the lab notebook in which they used during experiments. Our doc did submit his lab notebook and that was a big plus for us. The Intas guys only have claims, but they need to prove their claims, and so far, it only seems to be claims. We'll win this.

User Image The_Real_Heisenberg Posted - 11 hours ago

$ATOS Sometimes I wonder if I pissed someone off at Blackrock with my rants, and they just follow my account around shorting whatever I touch.

User Image chrundel Posted - 11 hours ago

$ATOS oh jeez, someone took their hand off the wheel… almost went green there for a second. 🙄

User Image Warrior199522 Posted - 12 hours ago

$ATOS guys , because its so boring haha , let me ask you a question . Last year remember we had that the run up for the 40mg dose ( 1 abstract ) from 0.90 to 2.30 .. why do you guys honestly think is the reason this hasn’t run up for ( 5 abstracts ) .. ?

User Image kinooo Posted - 13 hours ago

$ATOS I respect Quay as a scientist but he could learn something as a CEO by watching how the $CADL CEO operates. On social media his focus is on his company and cancer related subjects. No covid nonsense or political culture war stuff. Dr. Tak directly addresses questions and concerns from retail investors with pride and confidence. Maybe @MPJ_18 can tell him investors would like to see him work on his optics. An outsider looking at Quay’s X posts would come to the conclusion that $ATOS is nothing more than a pet project. Still bullish but there is always room for improvement.

User Image Bunster Posted - 13 hours ago

$ATOS IVE SAID THIS twice in last few days. What if the atm is to raise cash in case they have to pay off intas. One of the other most rightest posters on this mb , dcaj posted the same thing today.

User Image kinooo Posted - 13 hours ago

$ATOS $CADL $SLS the run has started!

User Image dcajic2 Posted - 13 hours ago

$ATOS they have asked in the last many times for shelf shares and lost. In reality if shareholders accepted that they needed the shelf shares to get a partner or a licensing deal they would not be in the place they are now. Stock price would have been so much higher. Now it is at least a two year wait for possibly calling the stock bullish and the real possibility when they lose patent the stock will fall under $1

Analyst Ratings
Ascendiant Capital Buy Sep 11, 24
HC Wainwright & Co. Buy Aug 12, 24
HC Wainwright & Co. Buy Jun 28, 24
Cantor Fitzgerald Overweight Jun 20, 24
Ascendiant Capital Buy Jun 6, 24
Cantor Fitzgerald Overweight May 14, 24
HC Wainwright & Co. Buy May 13, 24
HC Wainwright & Co. Buy Apr 16, 24
HC Wainwright & Co. Buy Apr 2, 24